United Therapeutics | UTHR - Pre Tax Profit



United Therapeutics reported $408.4M in Pre-Tax Profit for its fiscal quarter ending in June of 2025.


Pre Tax Profit Change Date
Amarin USD -13630000 197K Mar/2025
Ardelyx USD -19080000 23.76M Jun/2025
Baxter International USD -3000000 286M Mar/2025
Bayer EUR -426000000 2.26B Jun/2025
Biogen USD 744M 432.8M Jun/2025
BioMarin Pharmaceutical USD 297.87M 59.78M Jun/2025
Gilead Sciences USD 2.43B 780M Jun/2025
GlaxoSmithKline GBP 1.89B 221M Jun/2025
Halozyme Therapeutics USD 204.94M 61.11M Jun/2025
Insmed USD -320443000 64.77M Jun/2025
Ionis Pharmaceuticals USD 124M 271M Jun/2025
J&J USD 13.63B 8.21B Mar/2025
Moderna USD -818000000 146M Jun/2025
Pfizer USD 3.04B 259M Jun/2025
PTC Therapeutics USD -71052000 1B Jun/2025
Regeneron Pharmaceuticals USD 1.52B 613.7M Jun/2025
Sarepta Therapeutics USD 153.64M 537.16M Jun/2025
Teva Pharmaceutical Industries USD 203M 91M Jun/2025
United Therapeutics USD 408.4M 15.1M Jun/2025
Vertex Pharmaceuticals USD 1.28B 552.6M Jun/2025